Abnormal Uterine Bleeding



Abnormal Uterine Bleeding


Diane J. Youngs





Abnormal uterine bleeding (AUB) is a common problem for which pelvic sonography is indicated. Patients may see a health care provider because of infrequent menses, prolonged and heavy menses (menorrhagia), intermenstrual bleeding or spotting, postcoital spotting, or irregular and heavy menses (menometrorrhagia). Many possible diagnoses are considered in the evaluation of AUB. AUB may arise from structural causes, such as a lesion within the uterus or endometrium, or from a reproductive tract abnormality. AUB that is not caused by a structural problem is usually endocrine in nature and is called dysfunctional uterine bleeding (DUB). Causes of AUB are listed in Box 13-1.



Multiple treatment options exist for patients with AUB; the choice of treatment is guided by the patient’s symptoms, the impact of the symptoms on her quality of life, expectations of treatment, and whether the patient wishes to maintain fertility. Current treatments include hysterectomy, myomectomy, uterine artery embolization, magnetic resonance imaging (MRI)–guided focused ultrasound treatment, medical treatment based on hormone therapy (e.g., progestin or gonadotropin-releasing hormone agonists), and endometrial ablation for women who are finished with childbearing. The initial step in evaluating a woman with AUB is a pelvic examination, and if pathology is suspected, a pelvic sonogram should be obtained.


Pelvic sonography plays an important role in the diagnosis of uterine abnormalities in nonpregnant patients. The extended field of view provided by transabdominal pelvic sonography gives a global overview of the pelvis and is more likely to include large uterine masses such as fibroids. Transvaginal sonography provides the level of detail necessary to evaluate the endometrium and myometrium further for possible causes of AUB. Sonographic evaluation is useful in detecting anatomic causes of AUB, such as fibroids, adenomyosis, endometrial carcinoma, endometrial hyperplasia, endometrial polyps, and retained products of conception in a postpartum patient. Clinicians find pelvic sonography useful for development of a coherent treatment plan.



Normal Uterine Anatomy


The normal uterus is a pear-shaped organ located in the midpelvis, posterior to the urinary bladder and anterior to the rectum. The uterine divisions include the cervix, body, and fundus. The entrance to each fallopian tube, called the cornu (pl. cornua), is located in the uterine fundus. Uterine tissue consists of three layers: serosa, myometrium, and endometrium. The serosal layer (perimetrium) is the thin outer layer surrounding the uterus, the myometrium is the thick middle muscular layer, and the endometrium is the functional inner lining of the uterus (Fig. 13-2). The endometrium consists of a basal and a functional layer. The functional layer responds to hormonal stimulation throughout the menstrual cycle and is the layer that sheds during menses.



The uterine artery enters the uterus around the level of the isthmus, giving rise to the arcuate arteries, which lie in between the outer and intermediate layers of the myometrium. The arcuate arteries branch to radial arteries, extending through the intermediate myometrial layer and into the inner layer. The radial arteries branch to spiral arteries, which enter the endometrium and supply the functional layer.



Uterine Physiology


The uterus is the reproductive organ responsible for growth, maintenance, and delivery of the fetus. The secretory endometrium provides embryonic nourishment during early pregnancy, whereas the myometrium provides the muscular contractions necessary for delivery. Estrogen and progesterone are the hormones responsible for preparing the endometrium for pregnancy. During menses, lack of hormonal stimulation causes atrophy of the spiral arteries, and the functional layer of the endometrium sloughs and bleeds. Soon after menses, the proliferative phase of rebuilding and growth of endometrial tissue takes place under the influence of estrogen. After ovulation, under the influence of progesterone, the secretory phase of the uterus begins by stimulating glandular changes. These secretory changes cause the endometrial glands and stroma to produce glycogen-rich secretions capable of supporting an early embryo. If no pregnancy occurs, the corpus luteum of the ovary regresses, and the lack of hormones causes menses again. After menopause, the ovaries no longer function, and the endometrium undergoes atrophy.



Normal Sonographic Appearance


The normal sonographic appearance of the uterus depends on age, menstrual status, and parity. Uterine size varies throughout a woman’s life, depending on hormonal stimulation, pregnancy, and anatomic disorders. After menarche but before childbirth, the uterus measures approximately 8 cm long, 5 cm wide, and 4 cm thick. Parity generally increases uterine size by about 1 cm in all dimensions. After menopause, the uterus decreases in size. By age 65 years, uterine size ranges from 3.5 to 6.5 cm in length and 1 to 2 cm in diameter.1 The length and anteroposterior (AP) diameter of the uterus are obtained in the longitudinal midline view by measuring from the top of the uterine fundus to the external cervical os (Fig. 13-3).



The sonographic appearance of the normal endometrium depends on the menstrual phase or status of the patient and should be homogeneous in appearance and of appropriate thickness for the woman’s menstrual status (Table 13-1). An AP measurement of the double layer endometrial thickness should be obtained while in the longitudinal scanning plane, with placement of the calipers at the outer edges of each echogenic basal layer (Fig. 13-4, A). When intercavitary fluid is present, the endometrial layers should be measured separately, with the sum of the two measurements representing endometrial thickness (Fig. 13-4, B). For menstrual age women, normal double layer endometrial thickness is 4 to 14 mm, with maximum thickness occurring during the secretory phase. Endometrial pathology is very unlikely in a postmenopausal woman if endometrial thickness is less than 5 mm.2 Postmenopausal women taking hormone replacement therapy can experience a slightly thickened endometrium during the estrogen cycle (up to 8 mm) and should undergo repeat scanning during the progesterone cycle.




The functional layer of the endometrium demonstrates changes in sonographic appearance throughout the menstrual cycle. During menses, the endometrium is thin and appears as a hyperechoic line (Fig. 13-5, A). As the proliferative phase progresses and ovulation approaches, a triple line appearance is created by the opposite hyperechoic basal layers, hypoechoic functional layer, and hyperechoic endometrial cavity (Fig. 13-5, B). The secretory phase results in a thickened endometrium hyperechoic to the myometrium (Fig. 13-5, C). The inner layer of myometrium adjacent to the basal layer of the endometrium appears as a hypoechoic rim and is sometimes referred to as the junctional zone or subendometrial halo (Fig. 13-6); this should not be included in endometrial measurements.




The normal myometrium has a homogeneous echotexture, and the sonographer should assess for focal masses, diffuse heterogeneity, distortions in uterine contour, and size. The uterine veins are larger than the arteries and can be identified sonographically as focal anechoic areas around the periphery of the uterus (Fig. 13-7). In older women, atherosclerotic changes within the arcuate arteries of the uterus may be seen as hyperechoic, shadowing foci around the periphery of the uterus (Fig. 13-8).




Although there are many causes of AUB in a nonpregnant patient, sonographic assessment for endometrial and myometrial abnormalities is important because they are a common cause of AUB. Endometrial abnormalities may appear sonographically as a thickened endometrium, a focal mass, or a heterogeneous endometrium. Some common endometrial abnormalities that are discussed in this chapter include endometrial hyperplasia, endometrial carcinoma, polyps, changes caused by tamoxifen therapy, and retained products of conception. The most common cause of postmenopausal bleeding is endometrial atrophy, which appears sonographically as an endometrium less than 4 mm in thickness. Common myometrial abnormalities resulting in AUB include leiomyomas and adenomyosis. Myometrial abnormalities may affect the sonographic appearance of the uterus in the following ways: diffuse heterogeneity, focal hypoechoic or hyperechoic masses, distortion of the uterine contour, or overall uterine enlargement.



Myometrial Abnormalities


Leiomyoma


Leiomyomas, also called myomas or fibroids, are benign smooth muscle tumors that develop within the myometrium, but they may intrude into any of the uterine layers (Fig. 13-9). Uterine fibroids represent the most common pelvic tumor and are a leading cause of hysterectomy. Less commonly, fibroids can develop within the vagina, cervix, broad ligament, or fallopian tubes or on the omentum (so-called parasitic fibroids). They are more common in African American women than in women of other ethnicities.3 Fibroids range in size from 1 mm to more than 20 cm. Many women have multiple fibroids of varying sizes. Fibroids are known to grow in response to estrogen stimulation and tend to stabilize or regress during menopause.



Fibroids are myometrial in origin, and they can be surrounded by myometrium, intrude into the endometrium, or come in contact with the serosal layer (Fig. 13-10). Fibroids surrounded predominantly by myometrium are the most common and are referred to as intramural fibroids. Fibroids that project into the endometrium are referred to as submucosal fibroids. Subserosal fibroids are in contact with the serosal layer and distort the uterine contour. In some cases, subserosal fibroids grow off of a stalk into the adnexal regions seemingly separate from the uterus; these are referred to as pedunculated fibroids. Generally, only submucosal or large intramural fibroids cause AUB. Pedunculated fibroids are remote from the endometrium and myometrium and typically do not cause menorrhagia. The exact cause of menorrhagia with fibroids is unknown, but fibroid-associated changes in uterine vasculature, contractility, and endometrial surface area may contribute to the problem.4 Fibroids can undergo degeneration, which may cause pain.



Clinicians may suspect uterine fibroids based on patient history or physical examination. Pelvic sonography may be performed to assess the location and size of the fibroids, which can assist in development of a treatment plan. Some gynecologists obtain a sonogram before surgery to help determine the best surgical procedure plan for the patient. A patient who undergoes removal of fibroids (myomectomy) may need a combined approach in which the gynecologist removes large subserosal fibroids via an abdominal incision and removes submucosal fibroids with placement of an operative hysteroscope into the endometrial cavity. Treatment is not always necessary because many women with uterine fibroids are asymptomatic. Clinicians base treatment plans on the size and location of the fibroid, patient symptoms, and patient wishes regarding whether or not to undergo surgery.


Medical therapy for uterine fibroids includes birth control pills to reduce menstrual blood loss or short-term use of progestin to treat menorrhagia. Progestin-releasing intrauterine devices (IUDs) are also an option. A more recent treatment for uterine fibroids is uterine artery embolization. For this procedure, a catheter is introduced into the femoral artery and into the uterine artery. Microspheres injected through the catheter undergo embolization and block perfusion of the distal branches of the uterine artery that supply the fibroid, which results in necrosis and shrinkage of the fibroid. MRI-guided focused ultrasound therapy is another recent treatment for fibroids. This treatment involves using focused converging ultrasound beams to generate heat at a focal point causing necrosis of tissue. MRI is used for accurate targeting of the focal point and for monitoring tissue temperatures.4



Sonographic Findings


Fibroids visualized with sonography may cause obvious distortion of the uterine contour, generalized enlargement of the uterus, an altered echotexture, hypoechoic or hyperechoic focal masses, calcifications with shadowing, or heterogeneous masses with cystic areas (usually within degenerating fibroids). Fibroids are usually multiple. Documentation should include the size, location, and appearance of each fibroid. If it is not possible or practical to document each of the multiple fibroids, measurement and localization of the largest fibroid helps assess growth or regression on subsequent sonographic examinations. The fibrous nature of fibroids causes attenuation of the sound beam, and decreasing transducer frequency to increase penetration may be necessary to image large, dense fibroids.


Submucosal fibroids focally distort the endometrium, creating an area of increased or decreased echogenicity within the endometrium, which may be difficult to differentiate from endometrial polyps. Sonohysterography, the infusion of saline as a contrast agent into the uterine cavity, may help differentiate fibroids from polyps. Generally, submucosal fibroids tend to appear hypoechoic to the secretory endometrium, have a broad base of attachment, and display sonographic evidence of attenuation (Fig. 13-11). Intramural fibroids are relatively easy to visualize when they are hypoechoic and well encapsulated within the myometrium (Fig. 13-12).


Stay updated, free articles. Join our Telegram channel

Aug 27, 2016 | Posted by in ULTRASONOGRAPHY | Comments Off on Abnormal Uterine Bleeding

Full access? Get Clinical Tree

Get Clinical Tree app for offline access